LogicMark Inc
LGMK0.011USD
-0.001-5.74%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
1.92MCap. mercado
PérdidaP/E TTM
Más Datos de LogicMark Inc Compañía
LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform. The Company’s devices provide people with the ability to receive care at home and age independently. Its PERS devices incorporate two-way voice communication technology directly in the medical alert pendant. These PERS technologies are sold direct-to-consumer through the Company’s e-commerce Website, through dealers and distributors, as well as through the United States Veterans Health Administration (VHA). It provides no monthly fee products, which only require a one-time purchase expense, instead of a contract with recurring monthly charges. Its no monthly fee products contact family, friends, or 911 directly, eliminating the recurring monthly fee from a monitoring center. Its PERS products include Guardian Alert 911 Plus, Freedom Alert Plus, Guardian Alert 911, Freedom Alert Mini, and more.
Información de la empresa
Símbolo de cotizaciónLGMK
Nombre de la empresaLogicMark Inc
Fecha de salida a bolsaAug 02, 2013
Director ejecutivoMs. Chialin Simmons, J.D.
Número de empleados31
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 02
Dirección2801 Diode Lane
CiudadLOUISVILLE
Bolsa de valoresUS 'Other OTC' and Grey Market
PaísUnited States of America
Código postal40299
Teléfono15024427911
Sitio Webhttps://www.logicmark.com/
Símbolo de cotizaciónLGMK
Fecha de salida a bolsaAug 02, 2013
Director ejecutivoMs. Chialin Simmons, J.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Archer
Mr. Mark Archer
Chief Financial Officer
Chief Financial Officer
42.01K
--
Ms. Carine Schneider
Ms. Carine Schneider
Independent Director
Independent Director
880.00
--
Ms. Barbara Gutierrez
Ms. Barbara Gutierrez
Independent Director
Independent Director
860.00
--
Mr. John P. Pettitt
Mr. John P. Pettitt
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Robert A. Curtis, Pharm.D.
Dr. Robert A. Curtis, Pharm.D.
Independent Director
Independent Director
--
--
Ms. Chialin Simmons, J.D.
Ms. Chialin Simmons, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Archer
Mr. Mark Archer
Chief Financial Officer
Chief Financial Officer
42.01K
--
Ms. Carine Schneider
Ms. Carine Schneider
Independent Director
Independent Director
880.00
--
Ms. Barbara Gutierrez
Ms. Barbara Gutierrez
Independent Director
Independent Director
860.00
--
Mr. John P. Pettitt
Mr. John P. Pettitt
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Robert A. Curtis, Pharm.D.
Dr. Robert A. Curtis, Pharm.D.
Independent Director
Independent Director
--
--
Ms. Chialin Simmons, J.D.
Ms. Chialin Simmons, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Sabby Management, LLC
1.22%
Altium Capital Management LP
0.94%
L1 Capital Global Opportunities Master Fund Ltd.
0.85%
Hudson Bay Capital Management LP
0.26%
Renaissance Technologies LLC
0.11%
Other
96.63%
Accionistas
Accionistas
Proporción
Sabby Management, LLC
1.22%
Altium Capital Management LP
0.94%
L1 Capital Global Opportunities Master Fund Ltd.
0.85%
Hudson Bay Capital Management LP
0.26%
Renaissance Technologies LLC
0.11%
Other
96.63%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
2.16%
Corporation
0.85%
Hedge Fund
0.45%
Individual Investor
0.03%
Other
96.51%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
43
20.18M
3.57%
+19.04M
2025Q1
46
20.18M
3.50%
+19.04M
2024Q4
46
305.36K
10.34%
+114.75K
2024Q3
45
40.37K
8.11%
+7.47K
2024Q2
40
13.51K
15.38%
-18.17K
2024Q1
40
12.21K
20.39%
-17.08K
2023Q4
48
11.66K
19.75%
-18.11K
2023Q3
50
11.30K
93.79%
-14.22K
2023Q2
50
24.28K
166.02%
+15.47K
2023Q1
53
8.89K
204.40%
+594.00
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Sabby Management, LLC
7.04M
1.22%
+6.96M
+8467.91%
Mar 31, 2025
Altium Capital Management LP
5.40M
0.94%
+5.38M
+37367.42%
Mar 31, 2025
L1 Capital Global Opportunities Master Fund Ltd.
4.88M
0.85%
+4.38M
+876.25%
Mar 31, 2025
Hudson Bay Capital Management LP
1.50M
0.26%
+1.45M
+3091.49%
Mar 31, 2025
Renaissance Technologies LLC
612.11K
0.11%
+612.11K
--
Mar 31, 2025
Bigger Capital Funds, LP
490.00K
0.09%
+490.00K
--
Feb 18, 2025
Simmons (Chia-Lin J.D.)
123.03K
0.02%
--
--
Mar 27, 2025
Archer (Mark)
42.01K
0.01%
--
--
Mar 27, 2025
Jane Street Capital, L.L.C.
40.93K
0.01%
+40.93K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
21.72K
0%
+19.54K
+897.06%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Fecha
Tipo
Relación
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Oct 15, 2021
Merger
10<1
Oct 15, 2021
Merger
10<1
Ver más
